Form 4 · Filed Jun 18, 2026, 10:36 PM UTC
CVKD/Cadrenal Therapeutics, Inc.
Pham Quang X — Chairman and CEO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | S | sell | 513 | $3 | $1,621 | 128,589 |
| Jun 16, 2026 | S | sell | 3,613 | $3 | $11,489 | 129,102 |
Source: SEC EDGAR raw filing ↗ · Accession 0001213900-26-070248